AsiaInterventionPub Date : 2023-03-01DOI: 10.4244/AIJ-D-22-00052
Lisa Kettler, Philipp Nikolai, Heiko Mahrholdt, Peter Ong, Raffi Bekeredjian
{"title":"Early experience of fluid management and clinical benefit after transcatheter edge-to-edge repair in severe tricuspid regurgitation.","authors":"Lisa Kettler, Philipp Nikolai, Heiko Mahrholdt, Peter Ong, Raffi Bekeredjian","doi":"10.4244/AIJ-D-22-00052","DOIUrl":"https://doi.org/10.4244/AIJ-D-22-00052","url":null,"abstract":"","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":"9 1","pages":"95-96"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015486/pdf/AIJ-D-22-00052_Kettler.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9144725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
AsiaInterventionPub Date : 2023-03-01DOI: 10.4244/AIJ-E-22-00010
Dharam J Kumbhani, Ayman Elbadawi
{"title":"Transcatheter interventions for mitral regurgitation among patients with left ventricular dysfunction: repair or replacement?","authors":"Dharam J Kumbhani, Ayman Elbadawi","doi":"10.4244/AIJ-E-22-00010","DOIUrl":"https://doi.org/10.4244/AIJ-E-22-00010","url":null,"abstract":"","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":"9 1","pages":"16-17"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015473/pdf/AIJ-E-22-00010_Kumbhani.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9204065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
AsiaInterventionPub Date : 2023-03-01DOI: 10.4244/AIJ-D-22-00059
Adrian F Low, Nattawut Wongpraparut, Narathip Chunhamaneewat, Anuruck Jeamanukoolkit, Lee Tjen Jhung, Lee Zhen-Vin, Chen Ting Tan, Ho Hee Hwa, Rajinikanth Rajagopal, Achmad Fauzi Yahya, Ramneek Kaur, Manish Narang, Nick E J West
{"title":"Clinical use of optical coherence tomography during percutaneous coronary intervention and coronary procedures in Southeast Asia: a survey-based expert consensus summary.","authors":"Adrian F Low, Nattawut Wongpraparut, Narathip Chunhamaneewat, Anuruck Jeamanukoolkit, Lee Tjen Jhung, Lee Zhen-Vin, Chen Ting Tan, Ho Hee Hwa, Rajinikanth Rajagopal, Achmad Fauzi Yahya, Ramneek Kaur, Manish Narang, Nick E J West","doi":"10.4244/AIJ-D-22-00059","DOIUrl":"https://doi.org/10.4244/AIJ-D-22-00059","url":null,"abstract":"<p><p>Optical coherence tomography (OCT), an established intravascular imaging technique, enables rapid acquisition of high-resolution images during invasive coronary procedures to assist physician decision-making. OCT has utility in identifying plaque/lesion morphology (e.g., thrombus, degree of calcification, and presence of lipid) and vessel geometry (lesion length and vessel diameter) and in guiding stent optimisation through identification of malapposition and underexpansion. The use of OCT guidance during percutaneous coronary interventions (PCI) has demonstrated improved procedural and clinical outcomes in longitudinal registries, although randomised controlled trial data remain pending. Despite growing data and guideline endorsement to support OCT guidance during PCI, its use in different countries is not well established. This article is based on an advisory panel meeting that included experts from Southeast Asia (SEA) and is aimed at understanding the current clinical utility of intracoronary imaging and OCT, assessing the barriers and enablers of imaging and OCT adoption, and mapping a path for the future of intravascular imaging in SEA. This is the first Southeast Asian consensus that provides insights into the use of OCT from a clinician's point of view.</p>","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":"9 1","pages":"25-31"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015489/pdf/AIJ-D-22-00059_Low.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9143544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
AsiaInterventionPub Date : 2023-03-01DOI: 10.4244/AIJ-D-22-00074
Shao-Liang Chen
{"title":"DEFINITION criteria for left main bifurcation stenting - from clinical need to a formula.","authors":"Shao-Liang Chen","doi":"10.4244/AIJ-D-22-00074","DOIUrl":"https://doi.org/10.4244/AIJ-D-22-00074","url":null,"abstract":"<p><p>Percutaneous coronary intervention using drug-eluting stents for coronary bifurcation lesions is associated with higher rates of in-stent restenosis, myocardial infarction, and revascularisation as compared with non-coronary bifurcation lesions. The increased percentage of suboptimal results after stenting bifurcation lesions is largely, if not always, due to the extreme complexity of the anatomy. Obviously, one weapon (stenting technique) does not suit all enemies (bifurcation lesions with different anatomies), and it underscores the importance of establishing a stratification system.</p>","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":"9 1","pages":"20-24"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015477/pdf/AIJ-D-22-00074_Chen.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9139018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
AsiaInterventionPub Date : 2023-03-01DOI: 10.4244/AIJ-D-22-00049
Sara Hungerford, Nicole Bart, Ning Song, Paul Jansz, Gry Dahle, Alison Duncan, Christopher Hayward, David Muller
{"title":"Thirty-day and one-year outcomes following transcatheter mitral valve edge-to-edge repair versus transapical mitral valve replacement in patients with left ventricular dysfunction.","authors":"Sara Hungerford, Nicole Bart, Ning Song, Paul Jansz, Gry Dahle, Alison Duncan, Christopher Hayward, David Muller","doi":"10.4244/AIJ-D-22-00049","DOIUrl":"https://doi.org/10.4244/AIJ-D-22-00049","url":null,"abstract":"<p><strong>Background: </strong>A comparison of 30-day and 1-year clinical outcomes in patients with pre-existing left ventricular (LV) dysfunction undergoing transcatheter mitral valve edge-to-edge repair (TEER) or transcatheter transapical mitral valve replacement (TMVR) has not previously been reported.</p><p><strong>Aims: </strong>We aimed to compare 30-day and 1-year rates of all-cause and cardiovascular mortality as well as rehospitalisation for heart failure (HFH).</p><p><strong>Methods: </strong>All patients with severe (≥3+) symptomatic mitral regurgitation (MR) and an LV ejection fraction ≤50% who underwent TEER or TMVR over a 5-year period were evaluated.</p><p><strong>Results: </strong>Ninety-six patients (50 TEER, age 80±9 years, 70% secondary MR and 46 TMVR, age 72±9 years, 91% secondary MR) were studied. Baseline demographic and transthoracic echocardiogram characteristics were well-matched, with the exception of age (TEER 80±9 vs TMVR 72±9; p=0.01). Successful device implantation occurred in 96% of TEER patients and 97.8% of TMVR patients. Ninety-two percent of TEER patients had ≤2+MR predischarge, whilst no TMVR patient had ≥1+MR (p<0.01). No significant difference in the combined endpoint of 30-day all-cause mortality or HFH was observed (p>0.05). At 1 year, freedom from all-cause mortality and HFH was 79.2% across the entire study population but was significantly higher in patients undergoing TEER (TEER: n=45 [90%] hazard ratio 11.26, 95% confidence interval [CI]: 10.59-11.93 vs TMVR: n=39 [67.4%] 95% CI: 10.09-11.33; p=0.008).</p><p><strong>Conclusions: </strong>Despite comparable rates of successful device implantation, MR reduction, and 30-day all-cause mortality/HFH, TEER patients had lower all-cause mortality and HFH rates at 1 year.</p>","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":"9 1","pages":"78-86"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020820/pdf/AIJ-D-22-00049_Hungerford.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9139022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
AsiaInterventionPub Date : 2023-03-01DOI: 10.4244/AIJ-E-22-00007
Mirvat Alasnag, Fazila Malik, Ashok Seth
{"title":"WIN-APSIC Committee: a nexus for development & inclusion.","authors":"Mirvat Alasnag, Fazila Malik, Ashok Seth","doi":"10.4244/AIJ-E-22-00007","DOIUrl":"https://doi.org/10.4244/AIJ-E-22-00007","url":null,"abstract":"","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":"9 1","pages":"18-19"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015483/pdf/AIJ-E-22-00007_Alasnag.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9143541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
AsiaInterventionPub Date : 2023-03-01DOI: 10.4244/AIJ-D-22-00067
Hirofumi Hioki, Yusuke Watanabe, Hideyuki Kawashima, Toshiaki Otsuka, Jo Omiya, Kento Kito, Taiga Katayama, Akihisa Kataoka, Naoyuki Yokoyama, Ken Kozuma
{"title":"Predictors of bioprosthetic valve dysfunction after transcatheter aortic valve implantation.","authors":"Hirofumi Hioki, Yusuke Watanabe, Hideyuki Kawashima, Toshiaki Otsuka, Jo Omiya, Kento Kito, Taiga Katayama, Akihisa Kataoka, Naoyuki Yokoyama, Ken Kozuma","doi":"10.4244/AIJ-D-22-00067","DOIUrl":"https://doi.org/10.4244/AIJ-D-22-00067","url":null,"abstract":"<p><strong>Background: </strong>Recently, the Valve Academic Research Consortium (VARC)-3 criteria redefined bioprosthetic valve dysfunction (BVD) after transcatheter aortic valve implantation (TAVI). However, the rate of BVD is scarcely reported in current practice.</p><p><strong>Aims: </strong>We aimed to evaluate the rate and predictors of BVD after TAVI based on the VARC-3 criteria.</p><p><strong>Methods: </strong>We retrospectively analysed patients who had undergone TAVI using single-centre data. BVD was reported as exposure-adjusted event rates with a patient-year unit (per 100 patient-years). Predictors of BVD after TAVI were analysed using Fine-Gray competing risk regression to account for the competing risk of death.</p><p><strong>Results: </strong>Among 514 patients, the rate of BVD was 7.5 events per 100 patient-years (n=74) at a median follow-up of 1.9 years. The main cause of BVD was moderate or severe prosthesis-patient mismatch (PPM; n=59). The Fine-Gray model demonstrated that predilatation was associated with a lower rate of BVD, mainly moderate or severe PPM (adjusted subdistribution hazard ratio [sub-HR] 0.42, 95% confidence interval [CI]: 0.21-0.88). In a subgroup analysis, the patients with a small aortic annulus (area <400 mm<sup>2</sup> or perimeter <72 mm) tended to benefit from predilatation (p for interaction=0.03). The same regression model also demonstrated that a small balloon-expandable valve (BEV; ≤23 mm) was associated with a higher rate of BVD (adjusted sub-HR 2.46, 95% CI: 1.38-4.38).</p><p><strong>Conclusions: </strong>Our study suggested that the rate of BVD in patients undergoing TAVI is relatively low at midterm follow-up. Predilatation, particularly in small annuli and small BEV might have an impact on BVD, mainly caused by moderate or severe PPM, after TAVI.</p>","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":"9 1","pages":"87-94"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018288/pdf/AIJ-D-22-00067_Hioki.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9143542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
AsiaInterventionPub Date : 2023-03-01DOI: 10.4244/AIJ-D-22-00044
Masayoshi Kimura, Jun Yoshimura, Takaaki Ozawa, Jun Shiraishi, Masayuki Hyogo, Takahisa Sawada
{"title":"Overcoming complete collapse of a VBX stent graft with endovascular treatment using a bare nitinol stent.","authors":"Masayoshi Kimura, Jun Yoshimura, Takaaki Ozawa, Jun Shiraishi, Masayuki Hyogo, Takahisa Sawada","doi":"10.4244/AIJ-D-22-00044","DOIUrl":"https://doi.org/10.4244/AIJ-D-22-00044","url":null,"abstract":"","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":"9 1","pages":"66-67"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015479/pdf/AIJ-D-22-00044_Kimura.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9133437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}